Home > > > > > Report Detail

Global Drugs for Malaria Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 13-Sep-2022
No. of pages: 96
Inquire Before Buying

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Drugs for Malaria market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

In the U.S. market, the major manufacturers are Cipla, Guilin Southern Medicine, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aentis and Ajanta Pharma, etc, with about 73% market shares.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drugs for Malaria, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Drugs for Malaria.

The Drugs for Malaria market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drugs for Malaria market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drugs for Malaria companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Cipla

- Guilin Pharmaceutical

- IPCA Laboratories

- GlaxoSmithKline

- Mylan Labs

- Roche

- Novartis

- Sanofi Aventis

- Ajanta Pharma

Product Type Insights

Global markets are presented by Drugs for Malaria type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Drugs for Malaria are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Drugs for Malaria Segment by Type

- Aryl Aminoalcohol Compounds

- Antifolate Compounds

- Artemisinin Compounds

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Drugs for Malaria market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drugs for Malaria market.

Drugs for Malaria Segment by Application

- Prevention

- Treatment

- Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Drugs for Malaria market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Malaria market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Drugs for Malaria and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drugs for Malaria industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Malaria.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Drugs for Malaria Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Drugs for Malaria Product Introduction
1.2 Market by Type
1.2.1 Global Drugs for Malaria Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Aryl Aminoalcohol Compounds
1.2.3 Antifolate Compounds
1.2.4 Artemisinin Compounds
1.3 Market by Application
1.3.1 Global Drugs for Malaria Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Prevention
1.3.3 Treatment
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drugs for Malaria Market Size Estimates and Forecasts
2.2 Drugs for Malaria Market Size by Region: 2022 Versus 2028
2.2.1 Global Drugs for Malaria Revenue by Region: 2017-2022
2.2.2 Global Drugs for Malaria Revenue Forecast by Region (2023-2028)
2.2.3 Global Drugs for Malaria Revenue Market Share by Region (2017-2028)
3 Global Drugs for Malaria by Company
3.1 Global Drugs for Malaria Revenue by Company (2017-2022)
3.2 Global Drugs for Malaria Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Drugs for Malaria Companies around the World: Ranking by Revenue
3.3.2 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Drugs for Malaria Companies Headquarters & Product Type
3.4.1 Drugs for Malaria Companies Headquarters
3.4.2 Global Drugs for Malaria Companies Product & Service
3.4.3 Date of International Companies Enter into Drugs for Malaria Market
3.5 Global Drugs for Malaria Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Cipla
4.1.1 Cipla Corporation Information
4.1.2 Cipla Description, Business Overview
4.1.3 Cipla Drugs for Malaria Products Offered
4.1.4 Cipla Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.1.5 Cipla Drugs for Malaria Revenue by Product in 2021
4.1.6 Cipla Drugs for Malaria Revenue by Application in 2021
4.1.7 Cipla Drugs for Malaria Revenue by Geographic Area in 2021
4.1.8 Cipla Recent Developments
4.2 Guilin Pharmaceutical
4.2.1 Guilin Pharmaceutical Corporation Information
4.2.2 Guilin Pharmaceutical Description, Business Overview
4.2.3 Guilin Pharmaceutical Drugs for Malaria Products Offered
4.2.4 Guilin Pharmaceutical Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.2.5 Guilin Pharmaceutical Drugs for Malaria Revenue by Product in 2021
4.2.6 Guilin Pharmaceutical Drugs for Malaria Revenue by Application in 2021
4.2.7 Guilin Pharmaceutical Drugs for Malaria Revenue by Geographic Area in 2021
4.2.8 Guilin Pharmaceutical Recent Developments
4.3 IPCA Laboratories
4.3.1 IPCA Laboratories Corporation Information
4.3.2 IPCA Laboratories Description, Business Overview
4.3.3 IPCA Laboratories Drugs for Malaria Products Offered
4.3.4 IPCA Laboratories Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.3.5 IPCA Laboratories Drugs for Malaria Revenue by Product in 2021
4.3.6 IPCA Laboratories Drugs for Malaria Revenue by Application in 2021
4.3.7 IPCA Laboratories Drugs for Malaria Revenue by Geographic Area in 2021
4.3.8 IPCA Laboratories Recent Developments
4.4 GlaxoSmithKline
4.4.1 GlaxoSmithKline Corporation Information
4.4.2 GlaxoSmithKline Description, Business Overview
4.4.3 GlaxoSmithKline Drugs for Malaria Products Offered
4.4.4 GlaxoSmithKline Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.4.5 GlaxoSmithKline Drugs for Malaria Revenue by Product in 2021
4.4.6 GlaxoSmithKline Drugs for Malaria Revenue by Application in 2021
4.4.7 GlaxoSmithKline Drugs for Malaria Revenue by Geographic Area in 2021
4.4.8 GlaxoSmithKline Recent Developments
4.5 Mylan Labs
4.5.1 Mylan Labs Corporation Information
4.5.2 Mylan Labs Description, Business Overview
4.5.3 Mylan Labs Drugs for Malaria Products Offered
4.5.4 Mylan Labs Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.5.5 Mylan Labs Drugs for Malaria Revenue by Product in 2021
4.5.6 Mylan Labs Drugs for Malaria Revenue by Application in 2021
4.5.7 Mylan Labs Drugs for Malaria Revenue by Geographic Area in 2021
4.5.8 Mylan Labs Recent Developments
4.6 Roche
4.6.1 Roche Corporation Information
4.6.2 Roche Description, Business Overview
4.6.3 Roche Drugs for Malaria Products Offered
4.6.4 Roche Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.6.5 Roche Drugs for Malaria Revenue by Product in 2021
4.6.6 Roche Drugs for Malaria Revenue by Application in 2021
4.6.7 Roche Drugs for Malaria Revenue by Geographic Area in 2021
4.6.8 Roche Recent Development
4.7 Novartis
4.7.1 Novartis Corporation Information
4.7.2 Novartis Description, Business Overview
4.7.3 Novartis Drugs for Malaria Products Offered
4.7.4 Novartis Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.7.5 Novartis Drugs for Malaria Revenue by Product in 2021
4.7.6 Novartis Drugs for Malaria Revenue by Application in 2021
4.7.7 Novartis Drugs for Malaria Revenue by Geographic Area in 2021
4.7.8 Novartis Recent Development
4.8 Sanofi Aventis
4.8.1 Sanofi Aventis Corporation Information
4.8.2 Sanofi Aventis Description, Business Overview
4.8.3 Sanofi Aventis Drugs for Malaria Products Offered
4.8.4 Sanofi Aventis Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.8.5 Sanofi Aventis Drugs for Malaria Revenue by Product in 2021
4.8.6 Sanofi Aventis Drugs for Malaria Revenue by Application in 2021
4.8.7 Sanofi Aventis Drugs for Malaria Revenue by Geographic Area in 2021
4.8.8 Sanofi Aventis Recent Development
4.9 Ajanta Pharma
4.9.1 Ajanta Pharma Corporation Information
4.9.2 Ajanta Pharma Description, Business Overview
4.9.3 Ajanta Pharma Drugs for Malaria Products Offered
4.9.4 Ajanta Pharma Drugs for Malaria Revenue and Gross Margin (2017-2022)
4.9.5 Ajanta Pharma Drugs for Malaria Revenue by Product in 2021
4.9.6 Ajanta Pharma Drugs for Malaria Revenue by Application in 2021
4.9.7 Ajanta Pharma Drugs for Malaria Revenue by Geographic Area in 2021
4.9.8 Ajanta Pharma Recent Development
5 Breakdown Data by Type
5.1 Global Drugs for Malaria Revenue by Type (2017-2022)
5.2 Global Drugs for Malaria Revenue Forecast by Type (2023-2028)
5.3 Drugs for Malaria Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Drugs for Malaria Revenue by Application (2017-2022)
6.2 Global Drugs for Malaria Revenue Forecast by Application (2023-2028)
6.3 Drugs for Malaria Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Drugs for Malaria Market Size YoY Growth 2017-2028
7.2 North America Drugs for Malaria Market Facts & Figures by Country (2017-2028)
7.3 North America Drugs for Malaria Revenue by Type (2017-2022)
7.4 North America Drugs for Malaria Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Malaria Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Drugs for Malaria Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Drugs for Malaria Revenue by Type (2017-2022)
8.4 Asia-Pacific Drugs for Malaria Revenue by Application (2017-2022)
9 Europe
9.1 Europe Drugs for Malaria Market Size YoY Growth 2017-2028
9.2 Europe Drugs for Malaria Market Facts & Figures by Country (2017-2028)
9.3 Europe Drugs for Malaria Revenue by Type (2017-2022)
9.4 Europe Drugs for Malaria Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Drugs for Malaria Market Size YoY Growth 2017-2028
10.2 Latin America Drugs for Malaria Market Facts & Figures by Country (2017-2028)
10.3 Latin America Drugs for Malaria Revenue by Type (2017-2022)
10.4 Latin America Drugs for Malaria Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Drugs for Malaria Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Drugs for Malaria Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Drugs for Malaria Revenue by Type (2017-2022)
11.4 Middle East and Africa Drugs for Malaria Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Drugs for Malaria Supply Chain Analysis
12.2 Drugs for Malaria Key Raw Materials and Upstream Suppliers
12.3 Drugs for Malaria Clients Analysis
12.4 Drugs for Malaria Sales Channel and Sales Model Analysis
12.4.1 Drugs for Malaria Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Drugs for Malaria Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Drugs for Malaria Distributors
13 Market Dynamics
13.1 Drugs for Malaria Industry Trends
13.2 Drugs for Malaria Market Drivers
13.3 Drugs for Malaria Market Challenges
13.4 Drugs for Malaria Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Drugs for Malaria Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Aryl Aminoalcohol Compounds
Table 3. Major Companies of Antifolate Compounds
Table 4. Major Companies of Artemisinin Compounds
Table 5. Global Drugs for Malaria Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Drugs for Malaria Market Size by Region (US$ Million): 2022 VS 2028
Table 7. Global Drugs for Malaria Revenue by Region (2017-2022) & (US$ Million)
Table 8. Global Drugs for Malaria Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 9. Drugs for Malaria Revenue by Company (2017-2022) & (US$ Million)
Table 10. Drugs for Malaria Revenue Share by Company (2017-2022)
Table 11. Ranking of Global Top Drugs for Malaria Players by Revenue (US$ Million) in 2021
Table 12. Global Drugs for Malaria Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 13. Global Drugs for Malaria by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Malaria as of 2021)
Table 14. Global Drugs for Malaria Companies Headquarters
Table 15. Global Drugs for Malaria Companies Product & Service
Table 16. Date of International Companies Enter into Drugs for Malaria Market
Table 17. Global Drugs for Malaria Mergers & Acquisitions, Expansion Plans
Table 18. Cipla Corporation Information
Table 19. Cipla Description and Business Overview
Table 20. Cipla Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 21. Cipla Drugs for Malaria Product
Table 22. Cipla Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 23. Cipla Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 24. Cipla Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 25. Cipla Recent Development
Table 26. Guilin Pharmaceutical Corporation Information
Table 27. Guilin Pharmaceutical Description and Business Overview
Table 28. Guilin Pharmaceutical Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 29. Guilin Pharmaceutical Drugs for Malaria Product
Table 30. Guilin Pharmaceutical Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 31. Guilin Pharmaceutical Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 32. Guilin Pharmaceutical Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 33. Guilin Pharmaceutical Recent Development
Table 34. IPCA Laboratories Corporation Information
Table 35. IPCA Laboratories Description and Business Overview
Table 36. IPCA Laboratories Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 37. IPCA Laboratories Drugs for Malaria Product
Table 38. IPCA Laboratories Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 39. IPCA Laboratories Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 40. IPCA Laboratories Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 41. IPCA Laboratories Recent Development
Table 42. GlaxoSmithKline Corporation Information
Table 43. GlaxoSmithKline Description and Business Overview
Table 44. GlaxoSmithKline Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 45. GlaxoSmithKline Drugs for Malaria Product
Table 46. GlaxoSmithKline Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 47. GlaxoSmithKline Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 48. GlaxoSmithKline Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 49. GlaxoSmithKline Recent Development
Table 50. Mylan Labs Corporation Information
Table 51. Mylan Labs Description and Business Overview
Table 52. Mylan Labs Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 53. Mylan Labs Drugs for Malaria Product
Table 54. Mylan Labs Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 55. Mylan Labs Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 56. Mylan Labs Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 57. Mylan Labs Recent Development
Table 58. Roche Corporation Information
Table 59. Roche Description and Business Overview
Table 60. Roche Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 61. Roche Drugs for Malaria Product
Table 62. Roche Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 63. Roche Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 64. Roche Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 65. Novartis Corporation Information
Table 66. Novartis Description and Business Overview
Table 67. Novartis Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 68. Novartis Drugs for Malaria Product
Table 69. Novartis Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 70. Novartis Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 71. Novartis Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 72. Sanofi Aventis Corporation Information
Table 73. Sanofi Aventis Description and Business Overview
Table 74. Sanofi Aventis Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 75. Sanofi Aventis Drugs for Malaria Product
Table 76. Sanofi Aventis Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 77. Sanofi Aventis Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 78. Sanofi Aventis Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 79. Ajanta Pharma Corporation Information
Table 80. Ajanta Pharma Description and Business Overview
Table 81. Ajanta Pharma Drugs for Malaria Revenue (US$ Million) and Gross Margin (2017-2022)
Table 82. Ajanta Pharma Drugs for Malaria Product
Table 83. Ajanta Pharma Drugs for Malaria Revenue Proportion of Drugs for Malaria by Product in 2021
Table 84. Ajanta Pharma Drugs for Malaria Revenue Proportion of Drugs for Malaria by Application in 2021
Table 85. Ajanta Pharma Drugs for Malaria Revenue Proportion of Drugs for Malaria by Geographic Area in 2021
Table 86. Global Drugs for Malaria Revenue by Type (2017-2022) & (US$ Million)
Table 87. Global Drugs for Malaria Revenue by Application (2017-2022) & (US$ Million)
Table 88. Global Drugs for Malaria Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 89. North America Drugs for Malaria Revenue by Country (2017-2022) & (US$ Million)
Table 90. North America Drugs for Malaria Revenue by Country (2023-2028) & (US$ Million)
Table 91. North America Drugs for Malaria Revenue by Type (2017-2022) & (US$ Million)
Table 92. North America Drugs for Malaria Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia-Pacific Drugs for Malaria Revenue by Region (2017-2028) & (US$ Million)
Table 94. Asia-Pacific Drugs for Malaria Revenue by Region (2023-2028) & (US$ Million)
Table 95. Asia-Pacific Drugs for Malaria Revenue by Type (2017-2022) & (US$ Million)
Table 96. Asia-Pacific Drugs for Malaria Revenue by Application (2017-2022) & (US$ Million)
Table 97. Europe Drugs for Malaria Revenue by Country (2017-2022) & (US$ Million)
Table 98. Europe Drugs for Malaria Revenue by Country (2023-2028) & (US$ Million)
Table 99. Europe Drugs for Malaria Revenue by Type (2017-2022) & (US$ Million)
Table 100. Europe Drugs for Malaria Revenue by Application (2017-2022) & (US$ Million)
Table 101. Latin America Drugs for Malaria Revenue by Country (2017-2022) & (US$ Million)
Table 102. Latin America Drugs for Malaria Revenue by Country (2023-2028) & (US$ Million)
Table 103. Latin America Drugs for Malaria Revenue by Type (2017-2022) & (US$ Million)
Table 104. Latin America Drugs for Malaria Revenue by Application (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Drugs for Malaria Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Drugs for Malaria Revenue by Country (2023-2028) & (US$ Million)
Table 107. Middle East and Africa Drugs for Malaria Revenue by Type (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Drugs for Malaria Revenue by Application (2017-2022) & (US$ Million)
Table 109. Drugs for Malaria Key Raw Materials, Industry Status and Trend
Table 110. Drugs for Malaria Key Raw Materials and Upstream Suppliers
Table 111. Drugs for Malaria Clients Status and Trend
Table 112. Drugs for Malaria Typical Clients
Table 113. Drugs for Malaria Distributors
Table 114. Drugs for Malaria Market Trends
Table 115. Drugs for Malaria Market Drivers
Table 116. Drugs for Malaria Market Challenges
Table 117. Drugs for Malaria Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Drugs for Malaria Product Picture
Figure 2. Global Drugs for Malaria Revenue Market Share by Type in 2021 & 2028
Figure 3. Aryl Aminoalcohol Compounds Product Picture
Figure 4. Antifolate Compounds Product Picture
Figure 5. Artemisinin Compounds Product Picture
Figure 6. Global Drugs for Malaria Revenue Market Share by Application in 2021 & 2028
Figure 7. Prevention
Figure 8. Treatment
Figure 9. Others
Figure 10. Drugs for Malaria Report Years Considered
Figure 11. Global Drugs for Malaria Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Drugs for Malaria Market Size 2017-2028 (US$ Million)
Figure 13. Global Drugs for Malaria Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Drugs for Malaria Revenue Market Share by Region (2017-2028)
Figure 15. Drugs for Malaria Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Drugs for Malaria Revenue Market Share Forecast by Type (2017-2028)
Figure 17. Global Drugs for Malaria Revenue Market Share Forecast by Application (2017-2028)
Figure 18. North America Drugs for Malaria Revenue 2017-2028 (US$ Million)
Figure 19. North America Drugs for Malaria Revenue Market Share by Type (2017-2022)
Figure 20. North America Drugs for Malaria Revenue Market Share by Application (2017-2022)
Figure 21. Asia-Pacific Drugs for Malaria Revenue 2017-2028 (US$ Million)
Figure 22. Asia-Pacific Drugs for Malaria Revenue Market Share by Region (2017-2028)
Figure 23. Asia-Pacific Drugs for Malaria Revenue Market Share by Type (2017-2022)
Figure 24. Asia-Pacific Drugs for Malaria Revenue Market Share by Application (2017-2022)
Figure 25. Europe Drugs for Malaria Revenue Growth Rate 2017-2028 (US$ Million)
Figure 26. Europe Drugs for Malaria Revenue Market Share by Country (2017-2028)
Figure 27. Europe Drugs for Malaria Revenue Market Share by Type (2017-2022)
Figure 28. Europe Drugs for Malaria Revenue Market Share by Application (2017-2022)
Figure 29. Latin America Drugs for Malaria Revenue Growth Rate 2017-2028 (US$ Million)
Figure 30. Latin America Drugs for Malaria Revenue Market Share by Country (2017-2022)
Figure 31. Latin America Drugs for Malaria Revenue Market Share by Type (2017-2022)
Figure 32. Latin America Drugs for Malaria Revenue Market Share by Application (2017-2022)
Figure 33. Middle East and Africa Drugs for Malaria Revenue Growth Rate 2017-2028 (US$ Million)
Figure 34. Middle East and Africa Drugs for Malaria Revenue Market Share by Country (2017-2028)
Figure 35. Middle East and Africa Drugs for Malaria Revenue Market Share by Type (2017-2022)
Figure 36. Middle East and Africa Drugs for Malaria Revenue Market Share by Application (2017-2022)
Figure 37. Drugs for Malaria Supply Chain (Upstream and Downstream Market)
Figure 38. Global Production Market Share of Drugs for Malaria Raw Materials by Region in 2021
Figure 39. Drugs for Malaria Distribution Channels
Figure 40. Global Drugs for Malaria Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 41. Global Drugs for Malaria Percentage 2017-2028: Online Sales VS Offline Sales
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed
  • Global Dihydroartemisinin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......
  • Global Artemisinin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......
  • Dihydroartemisinin - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99
    The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......
  • Global Artemisinin Professional Survey Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Artemisinin Market Research Report 2023, Forecast to 2028
    Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131
    Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......
  • Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127
    Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......
  • Global Artemisinin Market Insights, Forecast to 2029
    Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108
    Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs